<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2209
  </number>
  <updateDate>
   2023-01-11T13:48:02Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:02Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-03-26
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 57 (Friday, March 26, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. FITZGERALD:H.R. 2209.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the U.S. Constitution.[Page H1693]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsju00
    </systemCode>
    <name>
     Judiciary Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsju08
      </systemCode>
      <name>
       Crime and Federal Government Surveillance Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-10-19T20:26:09Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-03-26T18:12:25Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-03-29T15:38:18Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-03-26T18:12:20Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Federal Initiative To Guarantee Health by Targeting Fentanyl Act
    </title>
    <congress>
     117
    </congress>
    <number>
     1910
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2021-05-18
     </actionDate>
     <text>
      Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     SIFT Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     2041
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2021-10-19
     </actionDate>
     <text>
      Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     Stopping Overdoses of Fentanyl Analogues Act
    </title>
    <congress>
     117
    </congress>
    <number>
     1006
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-03-25
     </actionDate>
     <text>
      Read twice and referred to the Committee on the Judiciary.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     Zero Tolerance for Deceptive Fentanyl Trafficking Act
    </title>
    <congress>
     117
    </congress>
    <number>
     4984
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2022-09-28
     </actionDate>
     <text>
      Read twice and referred to the Committee on the Judiciary.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-10-19
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsju08
      </systemCode>
      <name>
       Crime and Federal Government Surveillance Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-03-29
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-03-26
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-03-26
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-03-26
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-03-26
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     F000471
    </bioguideId>
    <fullName>
     Rep. Fitzgerald, Scott [R-WI-5]
    </fullName>
    <firstName>
     Scott
    </firstName>
    <lastName>
     Fitzgerald
    </lastName>
    <party>
     R
    </party>
    <state>
     WI
    </state>
    <district>
     5
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     H001091
    </bioguideId>
    <fullName>
     Rep. Hinson, Ashley [R-IA-1]
    </fullName>
    <firstName>
     Ashley
    </firstName>
    <lastName>
     Hinson
    </lastName>
    <party>
     R
    </party>
    <state>
     IA
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000576
    </bioguideId>
    <fullName>
     Rep. Grothman, Glenn [R-WI-6]
    </fullName>
    <firstName>
     Glenn
    </firstName>
    <lastName>
     Grothman
    </lastName>
    <party>
     R
    </party>
    <state>
     WI
    </state>
    <district>
     6
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000812
    </bioguideId>
    <fullName>
     Rep. Wagner, Ann [R-MO-2]
    </fullName>
    <firstName>
     Ann
    </firstName>
    <lastName>
     Wagner
    </lastName>
    <party>
     R
    </party>
    <state>
     MO
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-03-29
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     H001086
    </bioguideId>
    <fullName>
     Rep. Harshbarger, Diana [R-TN-1]
    </fullName>
    <firstName>
     Diana
    </firstName>
    <lastName>
     Harshbarger
    </lastName>
    <party>
     R
    </party>
    <state>
     TN
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-04-05
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000395
    </bioguideId>
    <fullName>
     Rep. Keller, Fred [R-PA-12]
    </fullName>
    <firstName>
     Fred
    </firstName>
    <lastName>
     Keller
    </lastName>
    <party>
     R
    </party>
    <state>
     PA
    </state>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-04-05
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000165
    </bioguideId>
    <fullName>
     Rep. Tiffany, Thomas P. [R-WI-7]
    </fullName>
    <firstName>
     Thomas
    </firstName>
    <lastName>
     Tiffany
    </lastName>
    <party>
     R
    </party>
    <state>
     WI
    </state>
    <middleName>
     P.
    </middleName>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-04-12
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000061
    </bioguideId>
    <fullName>
     Rep. Garcia, Mike [R-CA-25]
    </fullName>
    <firstName>
     Mike
    </firstName>
    <lastName>
     Garcia
    </lastName>
    <party>
     R
    </party>
    <state>
     CA
    </state>
    <district>
     25
    </district>
    <sponsorshipDate>
     2021-04-15
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001104
    </bioguideId>
    <fullName>
     Rep. Cawthorn, Madison [R-NC-11]
    </fullName>
    <firstName>
     Madison
    </firstName>
    <lastName>
     Cawthorn
    </lastName>
    <party>
     R
    </party>
    <state>
     NC
    </state>
    <district>
     11
    </district>
    <sponsorshipDate>
     2021-07-21
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000597
    </bioguideId>
    <fullName>
     Rep. Garbarino, Andrew R. [R-NY-2]
    </fullName>
    <firstName>
     Andrew
    </firstName>
    <lastName>
     Garbarino
    </lastName>
    <party>
     R
    </party>
    <state>
     NY
    </state>
    <middleName>
     R.
    </middleName>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-09-10
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M000871
    </bioguideId>
    <fullName>
     Rep. Mann, Tracey [R-KS-1]
    </fullName>
    <firstName>
     Tracey
    </firstName>
    <lastName>
     Mann
    </lastName>
    <party>
     R
    </party>
    <state>
     KS
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-09-20
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001135
    </bioguideId>
    <fullName>
     Rep. Steel, Michelle [R-CA-48]
    </fullName>
    <firstName>
     Michelle
    </firstName>
    <lastName>
     Steel
    </lastName>
    <party>
     R
    </party>
    <state>
     CA
    </state>
    <district>
     48
    </district>
    <sponsorshipDate>
     2021-09-21
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001108
    </bioguideId>
    <fullName>
     Rep. Comer, James [R-KY-1]
    </fullName>
    <firstName>
     James
    </firstName>
    <lastName>
     Comer
    </lastName>
    <party>
     R
    </party>
    <state>
     KY
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-02-09
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001213
    </bioguideId>
    <fullName>
     Rep. Steil, Bryan [R-WI-1]
    </fullName>
    <firstName>
     Bryan
    </firstName>
    <lastName>
     Steil
    </lastName>
    <party>
     R
    </party>
    <state>
     WI
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-02-09
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M000317
    </bioguideId>
    <fullName>
     Rep. Malliotakis, Nicole [R-NY-11]
    </fullName>
    <firstName>
     Nicole
    </firstName>
    <lastName>
     Malliotakis
    </lastName>
    <party>
     R
    </party>
    <state>
     NY
    </state>
    <district>
     11
    </district>
    <sponsorshipDate>
     2022-04-06
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Crime and Law Enforcement
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Drug trafficking and controlled substances
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Crime and Law Enforcement
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-03-26
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-06-09T14:40:49Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Stopping Overdoses of Fentanyl Analogues Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Stopping Overdoses of Fentanyl Analogues Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Stopping Overdoses of Fentanyl Analogues Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Stopping Overdoses of Fentanyl Analogues Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-03-26T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2209ih/xml/BILLS-117hr2209ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-10-19
   </actionDate>
   <text>
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-10-19
Crime and Federal Government Surveillance Subcommittee
hsju08
1
House committee actions
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committee
2021-03-29
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-03-26
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-03-26
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-03-26
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-26
9
Library of Congress
Introduced in House
IntroReferral
2021-03-26T18:12:25Z
Referred to
House
Judiciary Committee
2021-10-19T20:26:09Z
Referred to
Crime and Federal Government Surveillance Subcommittee
hsju08
hsju00
Standing
2021-03-26T18:12:20Z
Referred to
House
Energy and Commerce Committee
2021-03-29T15:38:18Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
H001091
1
Ashley
Rep. Hinson, Ashley [R-IA-1]
Hinson
R
2021-03-26
IA
G000576
6
Glenn
Rep. Grothman, Glenn [R-WI-6]
Grothman
R
2021-03-26
WI
W000812
2
Ann
Rep. Wagner, Ann [R-MO-2]
Wagner
R
2021-03-29
MO
H001086
1
Diana
Rep. Harshbarger, Diana [R-TN-1]
Harshbarger
R
2021-04-05
TN
K000395
12
Fred
Rep. Keller, Fred [R-PA-12]
Keller
R
2021-04-05
PA
T000165
7
Thomas
Rep. Tiffany, Thomas P. [R-WI-7]
Tiffany
P.
R
2021-04-12
WI
G000061
25
Mike
Rep. Garcia, Mike [R-CA-25]
Garcia
R
2021-04-15
CA
C001104
11
Madison
Rep. Cawthorn, Madison [R-NC-11]
Cawthorn
R
2021-07-21
NC
G000597
2
Andrew
Rep. Garbarino, Andrew R. [R-NY-2]
Garbarino
R.
R
2021-09-10
NY
M000871
1
Tracey
Rep. Mann, Tracey [R-KS-1]
Mann
R
2021-09-20
KS
S001135
48
Michelle
Rep. Steel, Michelle [R-CA-48]
Steel
R
2021-09-21
CA
C001108
1
James
Rep. Comer, James [R-KY-1]
Comer
R
2022-02-09
KY
S001213
1
Bryan
Rep. Steil, Bryan [R-WI-1]
Steil
R
2022-02-09
WI
M000317
11
Nicole
Rep. Malliotakis, Nicole [R-NY-11]
Malliotakis
R
2022-04-06
NY
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-03-26
2021-10-19
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
House
Crime and Law Enforcement
2021-05-18
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
CRS
Related bill
Federal Initiative To Guarantee Health by Targeting Fentanyl Act
HR
2021-10-19
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
CRS
Related bill
SIFT Act of 2021
HR
2021-03-25
Read twice and referred to the Committee on the Judiciary.
CRS
Identical bill
Stopping Overdoses of Fentanyl Analogues Act
S
2022-09-28
Read twice and referred to the Committee on the Judiciary.
CRS
Related bill
Zero Tolerance for Deceptive Fentanyl Trafficking Act
S
F000471
5
Scott
Rep. Fitzgerald, Scott [R-WI-5]
N
Fitzgerald
R
WI
Drug trafficking and controlled substances
2021-03-26
Introduced in House
 <p><b>Stopping Overdoses of Fentanyl Analogues Act</b></p> <p>This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.</p>
2021-06-09T14:40:49Z
00
2021-03-26T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2209ih/xml/BILLS-117hr2209ih.xml
Stopping Overdoses of Fentanyl Analogues Act
Stopping Overdoses of Fentanyl Analogues Act
Display Title
IH
Introduced in House
To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
Official Title as Introduced
IH
Introduced in House
Stopping Overdoses of Fentanyl Analogues Act
Short Title(s) as Introduced
HR
2023-01-11T13:48:02Z
2023-01-11T13:48:02Z
3.0.0
2021-05-18
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
CRS
Related bill
Federal Initiative To Guarantee Health by Targeting Fentanyl Act
HR
2021-10-19
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
CRS
Related bill
SIFT Act of 2021
HR
2021-03-25
Read twice and referred to the Committee on the Judiciary.
CRS
Identical bill
Stopping Overdoses of Fentanyl Analogues Act
S
2022-09-28
Read twice and referred to the Committee on the Judiciary.
CRS
Related bill
Zero Tolerance for Deceptive Fentanyl Trafficking Act
S
2021-10-19
Crime and Federal Government Surveillance Subcommittee
hsju08
1
House committee actions
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committee
2021-03-29
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-03-26
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-03-26
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-03-26
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-26
9
Library of Congress
Introduced in House
IntroReferral
F000471
5
Scott
Rep. Fitzgerald, Scott [R-WI-5]
N
Fitzgerald
R
WI
H001091
1
Ashley
Rep. Hinson, Ashley [R-IA-1]
Hinson
R
2021-03-26
IA
G000576
6
Glenn
Rep. Grothman, Glenn [R-WI-6]
Grothman
R
2021-03-26
WI
W000812
2
Ann
Rep. Wagner, Ann [R-MO-2]
Wagner
R
2021-03-29
MO
H001086
1
Diana
Rep. Harshbarger, Diana [R-TN-1]
Harshbarger
R
2021-04-05
TN
K000395
12
Fred
Rep. Keller, Fred [R-PA-12]
Keller
R
2021-04-05
PA
T000165
7
Thomas
Rep. Tiffany, Thomas P. [R-WI-7]
Tiffany
P.
R
2021-04-12
WI
G000061
25
Mike
Rep. Garcia, Mike [R-CA-25]
Garcia
R
2021-04-15
CA
C001104
11
Madison
Rep. Cawthorn, Madison [R-NC-11]
Cawthorn
R
2021-07-21
NC
G000597
2
Andrew
Rep. Garbarino, Andrew R. [R-NY-2]
Garbarino
R.
R
2021-09-10
NY
M000871
1
Tracey
Rep. Mann, Tracey [R-KS-1]
Mann
R
2021-09-20
KS
S001135
48
Michelle
Rep. Steel, Michelle [R-CA-48]
Steel
R
2021-09-21
CA
C001108
1
James
Rep. Comer, James [R-KY-1]
Comer
R
2022-02-09
KY
S001213
1
Bryan
Rep. Steil, Bryan [R-WI-1]
Steil
R
2022-02-09
WI
M000317
11
Nicole
Rep. Malliotakis, Nicole [R-NY-11]
Malliotakis
R
2022-04-06
NY
Drug trafficking and controlled substances
2021-03-26
Introduced in House
 <p><b>Stopping Overdoses of Fentanyl Analogues Act</b></p> <p>This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.</p>
2021-06-09T14:40:49Z
00
Stopping Overdoses of Fentanyl Analogues Act
Stopping Overdoses of Fentanyl Analogues Act
Display Title
IH
Introduced in House
To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
Official Title as Introduced
IH
Introduced in House
Stopping Overdoses of Fentanyl Analogues Act
Short Title(s) as Introduced
2021-10-19
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.